HIGHLIGHTS
- who: August and colleagues from the Chang Jung Christian University, Taiwan have published the Article: Gynostemma pentaphyllum for dyslipidemia: A systematic review of randomized controlled trials, in the Journal: (JOURNAL)
- how: Epidemiological data indicated that the global prevalence of dyslipidemia in 2019 was about 15.2% and the prevalence of dyslipidemia in adults in some developed countries was as high as 55% (Zeljkoviu0107 et_al 2019 Zhao 2019 Zokaei et_al 2020). The authors explored heterogeneity with prespecified subgroup analysis. The following comparisons were calculated whenever data were available Gynostemma pentaphyllum versus no intervention/placebo Gynostemma pentaphyllum . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.